These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25962973)

  • 1. Demonstration of Tightly Radiation-Controlled Molecular Switch Based on CArG Repeats by In Vivo Molecular Imaging.
    Hsieh YJ; Hwu L; Ke CC; Huang AL; Chen FD; Wu SJ; Chen SC; Zhao YH; Liu RS
    Mol Imaging Biol; 2015 Dec; 17(6):802-10. PubMed ID: 25962973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-tumor effect of suicide gene therapy using chimeric promoter plus radiotherapy on cancer cell lines].
    Sun WJ; Xiong J; Wang WF; Liao ZK; Zhou FX; Zhou YF
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):245-50. PubMed ID: 21575492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
    Hsieh YJ; Liu RS; Hwu L; Ke CC; Wang FH; Wang HE; Chen FD
    Anticancer Res; 2007; 27(3B):1571-9. PubMed ID: 17595778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
    Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.
    Scott SD; Joiner MC; Marples B
    Gene Ther; 2002 Oct; 9(20):1396-402. PubMed ID: 12365005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer.
    Xiong J; Sun WJ; Wang WF; Liao ZK; Zhou FX; Kong HY; Xu Y; Xie CH; Zhou YF
    Cancer; 2012 Jan; 118(2):536-48. PubMed ID: 21717442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
    Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
    Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.
    Naoum GE; Zhu ZB; Buchsbaum DJ; Curiel DT; Arafat WO
    Clin Transl Med; 2017 Dec; 6(1):11. PubMed ID: 28251571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of gene expression in retrovirus vectors by X-ray and proton beam radiation with artificially constructed promoters.
    Ogawa R; Morii A; Watanabe A; Cui ZG; Kagiya G; Fukuda S; Kume K; Hasegawa T; Hatashita M; Izumi H; Ishimoto T; Feril LB
    J Gene Med; 2012 May; 14(5):316-27. PubMed ID: 22438286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
    Coulter JA; McCarthy HO; Worthington J; Robson T; Scott S; Hirst DG
    Gene Ther; 2008 Apr; 15(7):495-503. PubMed ID: 18256696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular approaches to chemo-radiotherapy.
    Marples B; Greco O; Joiner MC; Scott SD
    Eur J Cancer; 2002 Jan; 38(2):231-9. PubMed ID: 11803140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the sequence requirements for the expression of a Xenopus borealis embryonic/larval skeletal actin gene.
    Lakin ND; Boardman M; Woodland HR
    Eur J Biochem; 1993 Jun; 214(2):425-35. PubMed ID: 8513792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of synthetic promoters for radiation-mediated gene therapy.
    Marples B; Scott SD; Hendry JH; Embleton MJ; Lashford LS; Margison GP
    Gene Ther; 2000 Mar; 7(6):511-7. PubMed ID: 10757025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatable promoters for use in gene therapy applications: modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP.
    Suzuki M; Singh RN; Crystal RG
    Hum Gene Ther; 1996 Oct; 7(15):1883-93. PubMed ID: 8894680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions.
    Mack CP; Owens GK
    Circ Res; 1999 Apr; 84(7):852-61. PubMed ID: 10205154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins.
    Rensen SS; Niessen PM; Long X; Doevendans PA; Miano JM; van Eys GJ
    Cardiovasc Res; 2006 Apr; 70(1):136-45. PubMed ID: 16451796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Greco O; Powell TM; Marples B; Joiner MC; Scott SD
    Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R/L, a double reporter mouse line that expresses luciferase gene upon Cre-mediated excision, followed by inactivation of mRFP expression.
    Jia J; Lin X; Lin X; Lin T; Chen B; Hao W; Cheng Y; Liu Y; Dian M; Yao K; Xiao D; Gu W
    Genome; 2016 Oct; 59(10):816-826. PubMed ID: 27643679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy.
    Lee EJ; Jameson JL
    Hum Gene Ther; 2002 Mar; 13(4):533-42. PubMed ID: 11874631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.